|
07/02/2013
Moscow, February 7, 2012, CIS Pharmaceutical Forum is a primary venue for major sector players in the CIS region including decision makers in regulatory space, international and local pharmaceutical companies, distributors, retailers and industry advisers.
Aleksandr Lobakov, Head of Healthcare and Pharmaceuticals Practice at BIC Securities, shared his views on the subject of “Latest trends in pharmaceutical mergers and acquisitions (M&A) space in the CIS region" and covered the following areas:
- Overview of key recent M&A transactions in the region
- Rationales for M&A from investors and local companies’ side
- Varying views of investors and local companies’ shareholders towards structuring of M&A deals
- Case study of “Akvion”/”Recordati” deal as an example of successfully structured and implemented transaction
 Return to archive
| 
